Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Graeme Bell Receives International Diabetes Prize

Published: Tuesday, December 18, 2012
Last Updated: Monday, December 17, 2012
Bookmark and Share
Prize includes a certificate of honor, a Japanese objet d’art and a $150,000 prize.

Graeme Ian Bell, the Louis Block Distinguished Service Professor of Medicine and Human Genetics and an investigator in the Kovler Diabetes Center at the University of Chicago, has been awarded the Manpei Suzuki International Prize for 2012 for his pioneering work in understanding the role of genetics in the diagnosis and treatment of diabetes.

Inaugurated in 2008 to commemorate the 15th anniversary of the Manpei Suzuki Diabetes Foundation, the prize honors “those who have enlightened researchers in the field of diabetes around the world with their original and excellent scientific achievements.”

Bell is being recognized, according to the selection committee, for his “extensive and groundbreaking contributions over many years to many landmark discoveries in diabetes research utilizing the powerful technologies of molecular biology and genetics.”

He will receive the prize and present a commemorative lecture at the award ceremony in Tokyo on Feb. 5, 2013.

Bell is the second scientist from the University of Chicago to win this prestigious award in the five years it has been given. His colleague Donald F. Steiner, the A.N. Pritzker Distinguished Service Professor Emeritus of Medicine and Biochemistry and Molecular Biology, received the award for 2009.

“This is a wonderful honor and a very pleasant surprise,” Bell said. “I am proud to find myself among such distinguished company and pleased that work from our laboratory and our many collaborators has had an impact on the field and been recognized in this way.”

Bell studies the genetics of diabetes mellitus and the biology of the insulin-secreting pancreatic beta-cell. He cloned and characterized many of the genes that are key in the regulation of glucose metabolism including insulin, glucagon, glucose transporters and many others.

Working with colleague Nancy Cox, Professor of Medicine and Human Genetics and Section Chief of Genetic Medicine, Bell discovered mutations in the genes for glucokinase and for three transcription factors that cause an early-onset form of diabetes called maturity-onset diabetes of the young.

Once thought to be very rare, this form of diabetes represents up to 5 percent of cases. Correct genetic diagnosis can alter treatment and improve clinical outcome.

“Perhaps the most remarkable aspect of Graeme’s research in diabetes is its scope,” Cox said. “He has made fundamental discoveries, but he also wants to make sure that patients benefit quickly from those advances. He engages with scientists in health care economics to evaluate the costs and benefits of translating the research findings into routine patient care, and works with clinicians to develop protocols for that translation. Few have the ability and the drive to do basic, translational and clinical research so effectively. This is a well-deserved honor.”

Bell is a key member of the University of Chicago Medicine’s diabetes genetics team, whose work involves using genetics to personalize treatment targeted to a patient’s specific genetic defect.

Babies with diabetes provide the most dramatic example of this approach. Nearly half have diabetes due to mutations in genes. Some of these children can be treated with pills that compensate for the genetic defect, rather than with insulin shots.

More than 1,500 patients and family members are now participating in genetic studies aimed at improving treatment through a better understanding of genetics.

The Manpei Suzuki Diabetes Foundation promotes research on diabetes by encouraging international contacts among young scientists.

Manpei Suzuki, former chairman of the Federation of Pharmaceutical Manufacturers’ Association of Japan, chairman of the Board of Directors of Sankyo Co. Ltd. and member of the Japanese House of Councilors, suffered from diabetes mellitus in the last years of his life.

In keeping with his last wishes, his widow Mitsu Suzuki established a foundation to support diabetes research.

According to the foundation, “more creative basic and applied studies are required due to the rapid aging of society which will occur in the 21st century.”

The international exchange among researchers that the foundation supports “will help improve health care technology and develop new health care resources in Japan. This, in turn, will lead to improvements in the prevention, diagnosis, and treatment of diabetes, a disease which affects many people and can have serious consequences for their quality of life.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

New Technique Targets Ataxia Gene
Scientists selectively turn off the disease-causing portion of a gene that causes a severe form of ataxia.
Thursday, July 14, 2016
New Microbiome Center to Merge Expertise of UChicago, MBL and Argonne
Researchers to study world of microbes across environments.
Wednesday, May 18, 2016
New Code for Control of Gene Expression
A new cellular signal discovered by a team of scientists at the University of Chicago and Tel Aviv University provides a promising new lever in the control of gene expression.
Thursday, February 18, 2016
Enormous Genetic Variation May Shield Tumors from Treatment
Debate over Darwinian selection vs. random mutations emerges at the tumor level.
Wednesday, November 11, 2015
Gut Bacteria Can Dramatically Amplify Cancer Immunotherapy
Manipulating microbes maximizes tumor immunity in mice.
Monday, November 09, 2015
New Form of DNA Modification May Carry Inheritable Information
Scientists have described the surprising discovery and function of a new DNA modification in insects, worms and algae.
Friday, May 08, 2015
Researchers Identify ‘Fat Gene’ Associated with Obesity
Mutations within the gene FTO have been implicated as the strongest genetic determinant of obesity risk in humans, but the mechanism behind this link remained unknown.
Monday, March 17, 2014
Genetic Analysis Reveals Insights into Genetics of OCD, Tourette’s
Major differences between the genetic makeup of obsessive-compulsive disorder and Tourette’s syndrome, providing the first direct confirmation that both are highly heritable.
Tuesday, November 05, 2013
Humans and Chimps Share Genetic Strategy in Battle Against Pathogens
Findings point to common ancestry.
Tuesday, February 19, 2013
Study Points to New Target for Cancers Resistant to Certain Drugs
A more sensitive method to analyze protein interactions has uncovered a new way that cancer cells may use the cell-surface molecule HER3 to drive tumor progression following treatment with HER1 and HER2 inhibitors.
Tuesday, September 11, 2012
Grapefruit Juice Lets Patients Take Lower Dose of Cancer Drug
First cancer study to harness drug-food interaction.
Thursday, August 09, 2012
Guidelines for Prostate Screening Widely Ignored, Study Finds
2008 recommendations from federal task force had no impact.
Monday, April 30, 2012
Chicago Cancer Genome Project Studies Genetics of 1,000 Tumors
Analyzing the genetics of cancers from different parts of the body may reveal surprising details for treatment and prevention.
Tuesday, December 29, 2009
Metabolic Syndrome Linked to Cold Tolerance
Researchers discover that many of the genetic variations that have enabled human populations to tolerate colder climates may also affect their susceptibility to metabolic syndrome.
Monday, February 18, 2008
Mutations in the Insulin Gene can Cause Neonatal Diabetes
Mutations in the insulin gene can cause permanent neonatal diabetes that affects very young children and results in lifelong dependence on insulin injections.
Friday, September 14, 2007
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Discovered Through ‘Big Data’ Analysis
Researchers at the SBP have identified over 100 new genetic regions that affect the immune response to cancer.
New Therapeutic Targets For Small Cell Lung Cancer Identified
Researchers at UTSW Medical Center have identified a protein termed ASCL1 that is essential to the development of small cell lung cancer and that, when deleted in the lungs of mice, prevents the cancer from forming.
Deciphering Inactive X Chromosomes
Untangling the Barr body of inactive X chromosomes valuable for understanding chromosome structure and gene expression.
Micro Disease-Detecting Senor Created
Researchers at McMaster University have created a microscopic disease-detecting sensor that can turn on to detect trace amounts of substances.
Liquid Biopsies Treating Ovarian Cancer
Researchers have discovered a promising monitor and treat recurrence of ovarian cancer. Detecting cancer long before tumours reappear.
Uncovering a New Principle in Chemotherapy Resistance in Breast Cancer
The NIH study has revealed an entirely unexpected process for acquiring drug resistance that bypasses the need to re-establish DNA damage repair in breast cancers that have mutant BRCA1 or BRCA2 genes.
Understanding Treatment Resistant Melanoma
Researchers have determined how advanced melanoma becomes resistant; a development toward developing treatments.
Investigating ‘Black Box’ of Human Genetics
Investigations into inactive X chromosomes have shown unusual DNA repeat elements are essential for maintaining 3D structure.
Liquid Biopsies: DNA Size Matters
Study finds circulating tumour DNA can be distinguished from healthy DNA through fragment size identification.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!